SCHEMBL264913

SCHEMBL264913

CCCCCCN(CCCCCC)c1ccc(C(=O)c2ccccc2C(=O)O)c(O)c1

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.91
KDM4E B2RXH2 1/20 0.91
POLB P06746 1/20 0.91
GAA P10253 1/20 0.91
KMT2A Q03164 3/20 0.73
MEN1 O00255 2/20 0.73
SMN1; SMN2 Q16637 1/20 0.73
L3MBTL1 Q9Y468 1/20 0.73
PTPN11 Q06124 2/20 0.47
PTPRO Q16827 1/20 0.47
BCL2L1 Q07817 1/20 0.47
MCL1 Q07820 1/20 0.47
PPARA Q07869 1/20 0.47
STAT3 P40763 1/20 0.42
KAT8 Q9H7Z6 2/20 0.41
NPC1 O15118 1/20 0.40
JAK2 O60674 1/20 0.40
RAB9A P51151 1/20 0.40
PAX8 Q06710 1/20 0.40
CNR2 P34972 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3659209 1.00 ALDH1A1 (0.91) ALDH1A1KDM4EPOLBGAAKMT2A
SCHEMBL3656127 1.00 ALDH1A1 (0.91) ALDH1A1KDM4EPOLBGAAKMT2A
SCHEMBL3660975 0.99 ALDH1A1 (0.93) ALDH1A1KDM4EPOLBGAAKMT2A
SCHEMBL9628808 0.95 ALDH1A1 (0.82) ALDH1A1KDM4EPOLBGAAKMT2A
SCHEMBL267885 0.95 ALDH1A1 (1.00) ALDH1A1KDM4EPOLBGAAKMT2A
SCHEMBL11080174 0.94 ALDH1A1 (0.84) ALDH1A1KDM4EPOLBGAAKMT2A
SCHEMBL10933445 0.93 ALDH1A1 (0.95) ALDH1A1KDM4EPOLBGAAKMT2A
SCHEMBL11083623 0.92 ALDH1A1 (0.78) ALDH1A1KDM4EPOLBGAAKMT2A
SCHEMBL264702 0.90 ALDH1A1 (0.85) ALDH1A1KDM4EPOLBGAAKMT2A
SCHEMBL11087979 0.89 ALDH1A1 (0.72) ALDH1A1KDM4EPOLBGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-58076458-A None JP disclosed
CN-121591603-A 2- [4- (Dihexylamino) -2-hydroxybenzoyl ] benzoic acid, preparation method and application 湖南鼎一致远科技发展股份有限公司 2026-03-03 CN disclosed
CN-121591603-A 2- [4- (Dihexylamino) -2-hydroxybenzoyl ] benzoic acid, preparation method and application 湖南鼎一致远科技发展股份有限公司 2026-03-03 CN disclosed
US-10435564-B2 Rhodamine-based colorant compound and process for producing same RIKEN (JP) 2019-10-08 US disclosed
US-20180244923-A1 RHODAMINE-BASED COLORANT COMPOUND AND PROCESS FOR PRODUCING SAME RIKEN (JP) 2018-08-30 US disclosed
EP-3345973-A1 RHODAMINE-BASED COLORANT COMPOUND AND PROCESS FOR PRODUCING SAME Riken (JP) 2018-07-11 EP disclosed
US-8134017-B1 Compound and use thereof RIKEN (JP) 2012-03-13 US disclosed
CN-101939309-A Uva filter based on ascorbic acid derivatives MERCK PATENT GMBH 2011-01-05 CN disclosed
US-20100322880-A1 UVA FILTERS BASED ON ASCORBIC ACID DERIVATIVES MERCK PATENT GMBH 2010-12-23 US disclosed
US-20100322880-A1 UVA FILTERS BASED ON ASCORBIC ACID DERIVATIVES MERCK PATENT GMBH 2010-12-23 US disclosed
US-20100322880-A1 UVA FILTERS BASED ON ASCORBIC ACID DERIVATIVES MERCK PATENT GMBH 2010-12-23 US disclosed
EP-2238121-A1 UVA FILTER BASED ON ASCORBIC ACID DERIVATIVES Merck Patent GmbH (DE) 2010-10-13 EP disclosed
WO-2009097951-A1 UVA FILTER BASED ON ASCORBIC ACID DERIVATIVES MERCK PATENT GMBH (DE) 2009-08-13 WO disclosed
JP-S5876458-A FLUORAN DERIVATIVE AND RECORDING MATERIAL USING THE SAME FUJI PHOTO FILM CO LTD 1983-05-09 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10435564-B2 Rhodamine-based colorant compound and process for producing same IK, RB1, HCCS ALDH1A1 899/4885KDM4E 906/4885POLB 4216/4885
US-20100322880-A1 UVA FILTERS BASED ON ASCORBIC ACID DERIVATIVES C1R, VDR, C1S ALDH1A1 80/4885KDM4E 3422/4885POLB 2018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.